Jutta Miller

Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1

Elizabeth Migoya, Raynald Bergeron, Jutta Miller et al. · Clinical Pharmacology & Therapeutics · 2010 · 177 citations

Life Sciences, Endocrinology, Pharmacology +17

Conversion of Stable Kidney Transplant Recipients From a Twice Daily Prograf-Based Regimen to a Once Daily Modified Release Tacrolimus-Based Regimen

Rita R. Alloway, S. Steinberg, Khalid Khalil et al. · Transplantation Proceedings · 2005 · 161 citations

Medicine, Nephrology, Pharmacotherapy +16

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

Matt S. Anderson, Thomas N. Kakuda, William D. Hanley et al. · Antimicrobial Agents and Chemotherapy · 2008 · 79 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Dose Proportionality of Oral Etoricoxib, a Highly Selective Cyclooxygenase‐2 Inhibitor, in Healthy Volunteers

Nancy Agrawal, Arturo G. Porras, Catherine Z. Matthews et al. · The Journal of Clinical Pharmacology · 2001 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients

Jules I. Schwartz, Nancy Agrawal, Peggy H. Wong et al. · The Journal of Clinical Pharmacology · 2001 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +13